Contrary to expectations, abnormalities in blood lipid levels may not be directly linked to cognitive decline in individuals with DM. This concept was explored in a new study published in the Journal of Diabetes & Metabolic Disorders.

The cross-sectional study included 365 adults with DM aged 18 years and above. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA) scale, with scores below 21 indicating impairment. Logistic regression models, adjusted for confounding variables, were used to analyze lipid parameters total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG).

Overall, 67.9% of participants exhibited cognitive impairment, while 70.4% had elevated LDL levels and 42.5% had low HDL. However, no statistically significant associations were observed between any lipid fraction and cognitive performance, even when analyses were stratified by sex.

Further longitudinal studies are necessary to clarify the long-term impact of dyslipidemia on cognitive health in diabetic populations and to uncover other potential contributing factors.